
1. cancer radiother. 2018 oct;22(6-7):496-501. doi: 10.1016/j.canrad.2018.06.007.
epub 2018 aug 4.

[radiotherapy hiv-infected patients].

[article french]

quéro l(1), gobert a(2), spano jp(2).

author information: 
(1)service de cancérologie-radiothérapie, hôpital saint-louis, 1, avenue
claude-vellefaux, 75010 paris, france. electronic address: laurent.quero@aphp.fr.
(2)groupe hospitalier pitié-salpêtrière-charles-foix, 75013 paris, france;
sorbonne université, 75006 paris, france.

since advent highly active antiretroviral therapy, cancer incidence is
still 2 3-fold higher patients infected human immunodeficiency virus
(hiv) general population, increased incidence malignancies
not associated acquired immunodeficiency syndrome (aids). hiv-infected
patients cancer treatment differ general population.
however, management patients particularities due to
preexisting comorbid conditions, including metabolic, cardiovascular, renal or
hepatic complications risk potential drug - drug interactions in
hiv-infected patients. review, described efficacy tolerance of
radiotherapy without chemotherapy frail population treated for
cancer. utilization modern radiotherapy techniques intensity-modulated
radiotherapy may improve treatment tolerance.

copyright © 2018 société française de radiothérapie oncologique (sfro). published
by elsevier masson sas. rights reserved.

doi: 10.1016/j.canrad.2018.06.007 
pmid: 30087055  [indexed medline]

